Viridian Therapeutics Price Chart
Viridian Therapeutics Volume Chart
Viridian Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
+0.26(+1.18%)
| Open | $22.08 |
|---|---|
| Close | $22.34 |
| Low | $22.08 |
| Low Change | 0.00 (0.00%) |
| High | $22.34 |
| High Change | +0.26 (+1.18%) |
| Range | $0.26 |
| Volume | 189.717K |
| Dollar Volume | $4.24M |
Regular Trading Hours
+0.07(+0.32%)
| Open | $22.02 |
|---|---|
| Close | $22.09 |
| Low | $21.62 |
| Low Change | -0.40 (-1.82%) |
| High | $22.23 |
| High Change | +0.21 (+0.95%) |
| Range | $0.61 |
| Volume | 816.913K |
| Dollar Volume | $18.05M |
Premarket
+0.15(+0.71%)
| Open | $21.50 |
|---|---|
| Close | $21.65 |
| Low | $21.50 |
| Low Change | 0.00 (0.00%) |
| High | $22.00 |
| High Change | +0.50 (+2.32%) |
| Range | $0.50 |
| Volume | 2.084K |
| Dollar Volume | $45.12K |
After Hours Yesterday
+0.26(+1.18%)
| Open | $22.08 |
|---|---|
| Close | $22.34 |
| Low | $22.08 |
| Low Change | 0.00 (0.00%) |
| High | $22.34 |
| High Change | +0.26 (+1.18%) |
| Range | $0.26 |
| Volume | 189.717K |
| Dollar Volume | $4.24M |
Regular Trading Hours Yesterday
+0.07(+0.32%)
| Open | $22.02 |
|---|---|
| Close | $22.09 |
| Low | $21.62 |
| Low Change | -0.40 (-1.82%) |
| High | $22.23 |
| High Change | +0.21 (+0.95%) |
| Range | $0.61 |
| Volume | 816.913K |
| Dollar Volume | $18.05M |
Premarket Yesterday
+0.15(+0.71%)
| Open | $21.50 |
|---|---|
| Close | $21.65 |
| Low | $21.50 |
| Low Change | 0.00 (0.00%) |
| High | $22.00 |
| High Change | +0.50 (+2.32%) |
| Range | $0.50 |
| Volume | 2.084K |
| Dollar Volume | $45.12K |
Viridian Therapeutics News
2 months agoinvesting.comComcast, Viridian Therapeutics jump premarket; Doximity slips
3 months agoinvesting.comViridian Therapeutics stock surges on positive trial results
4 months agoinvesting.comViridian Therapeutics stock tumbles after Amgen Tepezza data
5 months agobloomberg.comUS Premarket Movers: Alcoa, Spire, Sysco, Viridian Therapeutics
5 months agoinvesting.comViridian Therapeutics stock tumbles despite trial success
Viridian Therapeutics Top Trades
Viridian Therapeutics's top trade so far today returned +3.90%, while the top short trade returned -1.82%.
Viridian Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $22.60 |
|---|---|
| 10 Day Moving Average (SMA10) | $22.03 |
| 20 Day Moving Average (SMA20) | $20.69 |
| 50 Day Moving Average (SMA50) | $18.94 |
| 100 Day Moving Average (SMA100) | $17.92 |
| 200 Day Moving Average (SMA200) | $23.96 |
Viridian Therapeutics Statistics
| Average Volume (30 Days) | 1.91M |
|---|---|
| P/E Ratio (Current) | -7.45 |
| EPS (Current) | -$2.95 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$335.04M |
| Cash Ratio | 2.59 |
| Current Ratio | 16.95 |
| Quick Ratio | 16.95 |
| Debt to Equity | 0.54 |
| Enterprise Value | $2.68B |
| EV to EBITDA | -6.62 |
| EV to Sales | 37.71 |
| Price to Book | 3.76 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 35.03 |
| Return on Assets | -0.30% |
| Return on Equity | -0.50% |
Viridian Therapeutics Stock Splits
There have been 2 stock splits for Viridian Therapeutics (VRDN). The last reverse stock split occured on November 13, 2020 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Nov 13, 2020 | Reverse | 15:1 |
| Nov 7, 2016 | Reverse | 15:1 |
Viridian Therapeutics Dividends
There have been no dividends for Viridian Therapeutics (VRDN).